CYP2A6 longitudinal effects in young smokers

Nicotine and Tobacco Research

Volumn 18, Issue 2, 2016, Pages 196-203

  Cannon, Dale S ^a   Medina, Tait R ^b,c   Mermelstein, Robin J ^c   Hedeker, Donald ^d   Bakian, Amanda V ^a   Coon, Hilary ^a   Cook, Edwin H ^c   Hamil, Cindy ^a   Weiss, Robert B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2A6; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME METABOLISM; EUROPEAN; FEMALE; GENOTYPE; GROWTH CURVE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE DEPENDENCE SYNDROME SCALE; PHENOTYPE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; RISK FACTOR; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; YOUNG ADULT; AGE; CAUCASIAN; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; GENETICS; LONGITUDINAL STUDY; METABOLISM; SALIVA;

ADOLESCENT; AGE FACTORS; BIOMARKERS; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP2A6; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PHENOTYPE; SALIVA; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 84960097522     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv049     Document Type: Article

References (29)

1. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71. doi:10.1146/annurev.pharmtox.48.113006.094742.
2. Malaiyandi V, Sellers EM, Tyndale RF. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther. 2005;77(3):145-158. doi:10.1016/j. clpt.2004.10.011.
3. Ray R, Tyndale RF, Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet. 2009;23(3):252-261. doi:10.1080/01677060802572887.
4. Thorgeirsson TE, Gudbjartsson DF, Surakka I, et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet. 2010;42(5):448-453. doi:10.1038/ng.573.
5. Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics. 2007;119(1):e264-e274. doi:10.1542/peds.2006-1583.
6. Chenoweth MJ, O'Loughlin J, Sylvestre MP, Tyndale RF. CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenet Genomics. 2013;23(4):232-235. doi:10.1097/FPC.0b013e32835f834d.
7. Huang S, Cook DG, Hinks LJ, et al. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet Genomics. 2005;15(12):839-850. doi:01213011-200512000-00002.
8. O'Loughlin J, Paradis G, Kim W, et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control. 2004;13(4):422-428. doi:10.1136/tc.2003.007070.
9. Rodriguez S, Cook DG, Gaunt TR, Nightingale CM, Whincup PH, Day IN. Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. J Psychopharmacol. 2011;25(7):915-923. doi:10.1177/0269881111405352.
10. Rubinstein ML, Shiffman S, Moscicki AB, Rait MA, Sen S, Benowitz NL. Nicotine metabolism and addiction among adolescent smokers. Addiction. 2013;108(2):406-412. doi:10.1111/j.1360-0443.2012.04026.x.
11. Kumasaka N, Aoki M, Okada Y, et al. Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a Japanese population. PLoS One. 2012;7(9):e44507. doi:10.1371/journal.pone.0044507.
12. Cannon DS, Mermelstein RJ, Hedeker D, et al. Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults. Nicotine Tob Res. 2014;16(2):137-144. doi:10.1093/ntr/ntt125.
13. Dierker L, Mermelstein R. Early emerging nicotine-dependence symptoms: a signal of propensity for chronic smoking behavior in adolescents. J Pediatr. 2010;156(5):818-822. doi:10.1016/j.jpeds.2009.11.044.
14. Selya AS, Dierker LC, Rose JS, Hedeker D, Mermelstein RJ. Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence. Drug Alcohol Depend. 2012;124(3):311-318. doi:10.1016/j.drugalcdep.2012.02.004.
15. Engels WR. Exact tests for Hardy-Weinberg proportions. Genetics. 2009;183(4):1431-1441. doi:10.1534/genetics.109.108977.
16. Sterling KL, Mermelstein R, Turner L, Diviak K, Flay B, Shiffman S. Examining the psychometric properties and predictive validity of a youthspecific version of the Nicotine Dependence Syndrome Scale (NDSS) among teens with varying levels of smoking. Addict Behav. 2009;34(6-7):616-619. doi:10.1016/j.addbeh.2009.03.016.
17. Bloom AJ, Harari O, Martinez M, et al. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6. Hum Mol Genet. 2012;21(13):3050-3062. doi:10.1093/hmg/dds114.
18. Bloom J, Hinrichs AL, Wang JC, et al. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. Pharmacogenet Genomics. 2011;21(7):403-416. doi:10.1097/FPC.0b013e328346e8c0.
19. Greene WH. Accounting for excess zeros and sample selection in Poisson and negative binomial regression models. Working Paper EC-94-10. 1994:1-36. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1293115.Accessed November 3, 2014.
20. Lambert D. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics. 1992;34(1):1-14. http://dl.acm.org/citation.cfm?id=149270. Accessed November 3, 2014.
21. Long JS. Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, CA: Sage; 1997.
22. Hall DB. Zero-inflated Poisson and binomial regression with random effects: a case study. Biometrics. 2000;56(4):1030-1039. www.ncbi.nlm. nih.gov/pubmed/11129458. Accessed November 3, 2014.
23. Muthén BO, Curran PJ. General longitudinal modeling of individual differences in experimental designs: a latent variable framework for analysis and power estimation. Psychol Methods. 1997;24(4):371. doi:10.1037/1082-989X.2.4.371.
24. Muthén LK, Muthén BO. Mplus User's Guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 2012.
25. Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther. 2009;122(2):125-139. doi:10.1016/j. pharmthera.2009.02.003.
26. Lydon DM, Wilson SJ, Child A, Geier CF. Adolescent brain maturation and smoking: what we know and where we're headed. Neurosci Biobehav Rev. 2014;45:323-342. doi:10.1016/j.neubiorev.2014.07.003.
27. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33-51. doi:10.1037/0033-295X.111.1.33.
28. Mathew AR, Wahlquist AE, Garrett-Mayer E, Gray KM, Saladin ME, Carpenter MJ. Affective motives for smoking among early stage smokers. Nicotine Tob Res. 2014;16(10):1387-1393. doi:10.1093/ntr/ntu093.
29. Piper ME, Bolt DM, Kim SY, et al. Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol. 2008;117(4):747-761. doi:10.1037/a0013298.